Acurx Pharmaceuticals, Inc. (ACXP)
USD 0.72
(-16.62%)
USD 0.72
(-16.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Assets | 7.7 Million | 9.37 Million | 13.25 Million | 3.22 Million | 2.53 Million |
| Total Current Assets | 7.7 Million | 9.37 Million | 13.25 Million | 3.22 Million | 2.53 Million |
| Cash And Short Term Investments | 7.47 Million | 9.11 Million | 12.95 Million | 3.17 Million | 2.48 Million |
| Cash and Cash Equivalents | 7.47 Million | 9.11 Million | 12.95 Million | 3.17 Million | 2.48 Million |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 129.15 Thousand | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 105.77 Thousand | 264.95 Thousand | 295.3 Thousand | 48.6 Thousand | 48.1 Thousand |
| Total Non-Current Assets | - | - | - | - | - |
| Net PPE | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - |
| Good Will | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - |
| Tax Assets | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - |
| Other Assets | 234.93 Million | 264.95 Thousand | 295.3 Million | - | - |
| Total Liabilities | 3.04 Million | 2.06 Million | 843.9 Thousand | 522.43 Thousand | 1.71 Million |
| Total Current Liabilities | 3.04 Million | 2.06 Million | 843.9 Thousand | 472.55 Thousand | 1.71 Million |
| Account Payables | 3.81 | 2.06 Million | 63.37 | - | 2.30 |
| Tax Payables | - | - | - | - | - |
| Short Term Debt | - | - | - | 16.62 Thousand | - |
| Deferred Revenue | - | - | - | - | - |
| Other Current Liabilities | 3.04 Million | - | 843.84 Thousand | 455.93 Thousand | 1.71 Million |
| Total Non Current Liabilities | - | 2.06 Million | - | 49.87 Thousand | - |
| Long-Term Debt | - | - | - | 49.87 Thousand | - |
| Deferred Revenue Non Current | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - |
| Other Non Current Liabilities | - | 2.06 Million | - | - | - |
| Other Liabilities | 0.00 | -2.06 Million | - | - | - |
| Total Equity | 4.66 Million | 7.31 Million | 12.41 Million | 2.7 Million | 819.85 Thousand |
| Stock Holders Equity | 4.66 Million | 7.31 Million | 12.41 Million | 2.7 Million | 819.85 Thousand |
| Common Stock | 14.46 Thousand | 11.62 Thousand | 10.21 Thousand | 16.5 Million | 10.02 Million |
| Retained Earnings | -53.21 Million | -38.64 Million | -26.54 Million | -13.8 Million | -9.2 Million |
| Accumulated other comprehensive income | - | -38.64 Million | -26.54 Million | -13.8 Million | -9.2 Million |
| Common Stock Equity | 4.66 Million | 7.31 Million | 12.41 Million | 2.7 Million | 819.85 Thousand |
| Capital Lease Obligation | - | - | - | - | - |
| Total Investments | - | - | - | - | - |
| Total Debt | - | - | - | 66.5 Thousand | - |
| Net Debt | -7.47 Million | -9.11 Million | -12.95 Million | -3.1 Million | -2.48 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 6.58 Million | 9.1 Million | 7.7 Million | 7.7 Million | 7.15 Million | 9.23 Million |
| Total Current Assets | 6.58 Million | 9.1 Million | 7.7 Million | 7.7 Million | 7.15 Million | 9.23 Million |
| Cash And Short Term Investments | 6.36 Million | 8.92 Million | 7.47 Million | 7.47 Million | 7.05 Million | 9.14 Million |
| Cash and Cash Equivalents | 6.36 Million | 8.92 Million | 7.47 Million | 7.47 Million | 7.05 Million | 9.14 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | 51.12 Thousand | - | 129.15 Thousand | 129.15 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | 168.4 Thousand | 187.9 Thousand | 105.77 Thousand | 105.77 Thousand | 105.72 Thousand | 89.94 Thousand |
| Total Non-Current Assets | - | - | 234.93 Million | - | - | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | 234.93 Million | - | - | - |
| Other Assets | 219.53 Million | 187.9 Million | -234.93 Million | 234.93 Million | 105.72 Million | 89.94 Million |
| Total Liabilities | 3.15 Million | 3.11 Million | 3.04 Million | 3.04 Million | 3.22 Million | 3.01 Million |
| Total Current Liabilities | 3.15 Million | 3.11 Million | 3.04 Million | 3.04 Million | 3.22 Million | 3.01 Million |
| Account Payables | 10.13 Thousand | 3.11 Million | 3.81 | 3.81 | 11.72 | 12.88 |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 3.14 Million | - | 3.04 Million | 3.04 Million | 3.22 Million | 3.01 Million |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 3.42 Million | 5.99 Million | 4.66 Million | 4.66 Million | 3.93 Million | 6.21 Million |
| Stock Holders Equity | 3.42 Million | 5.99 Million | 4.66 Million | 4.66 Million | 3.93 Million | 6.21 Million |
| Common Stock | 15.99 Thousand | 15.75 Thousand | 14.46 Thousand | 14.46 Thousand | 13 Thousand | 13 Thousand |
| Retained Earnings | -61.71 Million | -57.59 Million | -53.21 Million | -53.21 Million | -48.1 Million | -44.98 Million |
| Accumulated other comprehensive income | - | - | - | - | - | - |
| Common Stock Equity | 3.42 Million | 5.99 Million | 4.66 Million | 4.66 Million | 3.93 Million | 6.21 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - |
| Net Debt | -6.36 Million | -8.92 Million | -7.47 Million | -7.47 Million | -7.05 Million | -9.14 Million |
8542
VUL
E8X
BBN
000660
002611